Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches

Recent findings in animals and in humans have shown that cannabinoid type 1 receptor antagonists are suitable to become the most promising validated class of drugs to tackle obesity and related disorders. This mini-review will provide a concise and updated revision of the state of art on this topic.

Saved in:

Bibliographic Details
Published in:	Mini reviews in medicinal chemistry Vol. 7; no. 1; p. 21
Main Authors:	Cervino, C, Pasquali, R, Pagotto, U
Format:	Journal Article
Language:	English
Published:	Netherlands 01-01-2007
Subjects:	Cannabinoid Receptor Agonists Cannabinoid Receptor Antagonists Humans Metabolic Syndrome - drug therapy Obesity - drug therapy Piperidines - pharmacology Piperidines - therapeutic use Pyrazoles - pharmacology Pyrazoles - therapeutic use
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Recent findings in animals and in humans have shown that cannabinoid type 1 receptor antagonists are suitable to become the most promising validated class of drugs to tackle obesity and related disorders. This mini-review will provide a concise and updated revision of the state of art on this topic.
ISSN:	1389-5575
DOI:	10.2174/138955707779317812